(Q45953898)

18 December 2017

title

Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. (English)

1 reference

18 December 2017

1 reference

1 reference

Chen Xu Wang

1

1 reference

18 December 2017

Xiuqing Ding

2

1 reference

18 December 2017

Raza Noor

3

1 reference

18 December 2017

Christina Pegg

4

1 reference

18 December 2017

Chunyan He

5

1 reference

18 December 2017

Ashfaq Shuaib

6

1 reference

18 December 2017

publication date

24 June 2009

1 reference

18 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

18 December 2017

volume

29

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

1683-1694

1 reference

18 December 2017

Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Multiple roles for MMPs and TIMPs in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Recanalization and reperfusion therapies for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Hyperthermia masks the neuroprotective effects of tissue plaminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Blood-brain barrier tight junction permeability and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Reduction of ischemic brain injury in rats with normothermic and hyperthermic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Medical significance of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

An improved version of embolic model of brain ischemic injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Involvement of inflammatory cytokines in central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Neuroprotective effects of free radical scavengers in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Critical role of microvasculature basal lamina in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiinflammatory properties of PPARgamma agonists following ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

inferred from DOI database lookup

7 January 2021

based on heuristic

Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JCBFM.2009.87

1 reference

18 December 2017

1 reference

18 December 2017